MMP Capital reported that it recorded $44 million in originations in December and $110 million in Q4/23 alone, leading to a company-record of more than $358 million in originations in 2023.

“Our team’s hard work, and commitment to excellence in the financing for small business has been the biggest factor in our success,” John-Paul Smolenski, president and CEO of MMP Capital, said. “MMP Capital’s growth is also fueled by our organic development and strong reputation as the leading financier in aesthetic medical devices in the U.S. We are grateful for our customers, allowing us to be a part of their success. It is a special feeling meeting with a new business, financing their first device and helping them grow our business alongside theirs providing financing for several devices over the next five to 10 years.

“The credit crunch that most banks are experiencing has created a perfect storm of opportunities for MMP Capital to introduce ourselves to business owners all over the country. New medical device vendors whose prior lending relationships have either soured or are offline altogether have also contributed to new opportunities. In a day where most companies outsource their customer service, and customers are waiting online for hours trying to get a straight answer, if at all, MMP Capital’s efficient and cost-effective approach has made it easy for small business owners to achieve their financing goals.”